S|P|O
FGFR2|participates_in|VEGFR2 mediated cell proliferation
KDR|participates_in|VEGFR2 mediated cell proliferation
FGFR2|participates_in|PI3K/AKT activation
INSR|participates_in|PI3K/AKT activation
FGFR2|causes or contributes to condition|LADD syndrome
FGFR3|causes or contributes to condition|LADD syndrome
FGFR2|participates_in|IRS-related events triggered by IGF1R
IGF1R|participates_in|IRS-related events triggered by IGF1R
KIT|participates_in|PI3K/AKT activation
FGFR2|causes or contributes to condition|Jackson-Weiss syndrome
FGFR1|causes or contributes to condition|Jackson-Weiss syndrome
FGFR2|participates_in|Axon guidance
EPHA2|participates_in|Axon guidance
FGFR2|causes or contributes to condition|endometrium adenocarcinoma
EGFR|causes or contributes to condition|endometrium adenocarcinoma
FGFR2|participates_in|Signaling by Interleukins
CSF1R|participates_in|Signaling by Interleukins
FGFR2|participates_in|PI3K Cascade
FGFR4|participates_in|PI3K Cascade
FGFR2|participates_in|Signaling by VEGF
FLT1|participates_in|Signaling by VEGF
FLT4|participates_in|Signaling by VEGF
FGFR2|participates_in|Signaling by NTRKs
NGFR|participates_in|Signaling by NTRKs
MET|participates_in|PI3K/AKT activation
PDGFRA|participates_in|PI3K/AKT activation
PDGFRB|participates_in|PI3K/AKT activation
FGFR2|participates_in|SOS-mediated signalling
TEK|participates_in|SOS-mediated signalling
FLT3|participates_in|Signaling by Interleukins
NTRK1|participates_in|PI3K/AKT activation
FGFR2|participates_in|Signaling by NTRK1 (TRKA)
NTRK2|participates_in|Signaling by NTRK1 (TRKA)
KDR|subClassOf|gene
INSR|subClassOf|gene
KDR|causes or contributes to condition|Lung adenocarcinoma
FGFR3|causes or contributes to condition|Lung adenocarcinoma
IGF1R|subClassOf|gene
KIT|participates_in|VEGFR2 mediated cell proliferation
FGFR1|participates_in|VEGFR2 mediated cell proliferation
KDR|participates_in|EPHA-mediated growth cone collapse
EPHA2|participates_in|EPHA-mediated growth cone collapse
KDR|causes or contributes to condition|Esophageal neoplasm
EGFR|causes or contributes to condition|Esophageal neoplasm
CSF1R|subClassOf|gene
FGFR4|causes or contributes to condition|Lung adenocarcinoma
KDR|participates_in|Neurophilin interactions with VEGF and VEGFR
FLT1|participates_in|Neurophilin interactions with VEGF and VEGFR
KDR|causes or contributes to condition|capillary infantile hemangioma
FLT4|causes or contributes to condition|capillary infantile hemangioma
KDR|causes or contributes to condition|Schizophrenia
NGFR|causes or contributes to condition|Schizophrenia
MET|causes or contributes to condition|Esophageal neoplasm
PDGFRA|participates_in|VEGFR2 mediated cell proliferation
PDGFRB|participates_in|VEGFR2 mediated cell proliferation
KDR|causes or contributes to condition|temporal lobe epilepsy
TEK|causes or contributes to condition|temporal lobe epilepsy
FLT3|subClassOf|gene
NTRK1|causes or contributes to condition|Schizophrenia
NTRK2|causes or contributes to condition|Lung adenocarcinoma
FGFR3|participates_in|PI3K/AKT activation
INSR|causes or contributes to condition|Morgagni diaphragmatic hernia
IGF1R|causes or contributes to condition|Morgagni diaphragmatic hernia
FGFR1|participates_in|PI3K/AKT activation
EPHA2|subClassOf|gene
EGFR|participates_in|PI3K/AKT activation
FGFR4|participates_in|PI3K/AKT activation
INSR|participates_in|Signal Transduction
FLT1|participates_in|Signal Transduction
FLT4|subClassOf|gene
INSR|participates_in|Signaling by NTRKs
INSR|participates_in|Insulin receptor signalling cascade
TEK|participates_in|Insulin receptor signalling cascade
INSR|causes or contributes to condition|Lewy bodies
NTRK1|causes or contributes to condition|Lewy bodies
NTRK2|causes or contributes to condition|Lewy bodies
FGFR3|participates_in|IGF1R signaling cascade
IGF1R|participates_in|IGF1R signaling cascade
FGFR3|causes or contributes to condition|testicular germ cell tumor
KIT|causes or contributes to condition|testicular germ cell tumor
FGFR3|causes or contributes to condition|gliosarcoma
FGFR1|causes or contributes to condition|gliosarcoma
FGFR3|participates_in|Axon guidance
EGFR|causes or contributes to condition|gliosarcoma
FGFR3|participates_in|Signaling by Interleukins
FGFR3|participates_in|PI3K Cascade
FLT1|causes or contributes to condition|Lung adenocarcinoma
FGFR3|participates_in|Signaling by VEGF
FGFR3|participates_in|Signaling by NTRKs
FGFR3|participates_in|SOS-mediated signalling
FGFR3|participates_in|IRS-related events triggered by IGF1R
IGF1R|causes or contributes to condition|Abnormal lung morphology
KIT|causes or contributes to condition|Abnormal lung morphology
FGFR1|participates_in|IGF1R signaling cascade
IGF1R|causes or contributes to condition|Squamous cell lung carcinoma
EPHA2|causes or contributes to condition|Squamous cell lung carcinoma
IGF1R|causes or contributes to condition|Adrenocortical carcinoma
EGFR|causes or contributes to condition|Adrenocortical carcinoma
IGF1R|causes or contributes to condition|Breast carcinoma
CSF1R|causes or contributes to condition|Breast carcinoma
FGFR4|participates_in|IRS-related events triggered by IGF1R
IGF1R|causes or contributes to condition|Neoplasm of the skin
FLT1|causes or contributes to condition|Neoplasm of the skin
pesticide|interacts with|IGF1R
pesticide|interacts with|NGFR
MET|participates_in|IRS-related events triggered by IGF1R
PDGFRA|causes or contributes to condition|Abnormal lung morphology
PDGFRB|participates_in|IGF1R signaling cascade
TEK|participates_in|IRS-related events triggered by IGF1R
IGF1R|causes or contributes to condition|Lewy bodies
KIT|participates_in|Axon guidance
KIT|participates_in|TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
EGFR|participates_in|TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
KIT|causes or contributes to condition|Breast carcinoma
KIT|causes or contributes to condition|Neoplasm of the skin
KIT|participates_in|Signaling by VEGF
KIT|participates_in|Signaling by NTRKs
KIT|causes or contributes to condition|cutaneous melanoma
PDGFRA|causes or contributes to condition|cutaneous melanoma
KIT|participates_in|SOS-mediated signalling
KIT|causes or contributes to condition|Acute myelomonocytic leukemia
FLT3|causes or contributes to condition|Acute myelomonocytic leukemia
KIT|participates_in|Signaling by NTRK1 (TRKA)
FGFR1|participates_in|Axon guidance
FGFR1|participates_in|Signal transduction by L1
EGFR|participates_in|Signal transduction by L1
FGFR1|causes or contributes to condition|Neoplasm of the breast
CSF1R|causes or contributes to condition|Neoplasm of the breast
FGFR1|participates_in|PI3K Cascade
FGFR1|participates_in|Signaling by VEGF
FGFR1|participates_in|Signaling by NTRKs
FGFR1|causes or contributes to condition|gemistocytic astrocytoma
MET|causes or contributes to condition|gemistocytic astrocytoma
FGFR1|participates_in|SOS-mediated signalling
FGFR1|participates_in|Signaling by Interleukins
FGFR1|causes or contributes to condition|pilomyxoid astrocytoma
NTRK2|causes or contributes to condition|pilomyxoid astrocytoma
EGFR|participates_in|Axon guidance
EPHA2|causes or contributes to condition|Neoplasm
CSF1R|causes or contributes to condition|Neoplasm
FGFR4|participates_in|Axon guidance
EPHA2|subClassOf|protein_coding_gene
FLT1|subClassOf|protein_coding_gene
NGFR|subClassOf|protein_coding_gene
MET|participates_in|Axon guidance
PDGFRA|participates_in|Axon guidance
PDGFRB|participates_in|Axon guidance
TEK|participates_in|Axon guidance
NTRK1|subClassOf|gene
NTRK2|subClassOf|gene
EGFR|participates_in|Signaling by Interleukins
EGFR|participates_in|Signaling by VEGF
pesticide|interacts with|EGFR
EGFR|participates_in|SOS-mediated signalling
EGFR|causes or contributes to condition|Alcoholism
NTRK2|causes or contributes to condition|Alcoholism
FGFR4|participates_in|Signaling by Interleukins
FLT1|causes or contributes to condition|Breast carcinoma
CSF1R|subClassOf|protein_coding_gene
CSF1R|causes or contributes to condition|Acute megakaryocytic leukemia
MET|causes or contributes to condition|Acute megakaryocytic leukemia
PDGFRA|participates_in|Signaling by Interleukins
PDGFRB|participates_in|Signaling by Interleukins
TEK|participates_in|Signaling by Interleukins
FGFR4|participates_in|IGF1R signaling cascade
FGFR4|participates_in|Signaling by VEGF
FGFR4|participates_in|Signaling by NTRKs
FGFR4|participates_in|SOS-mediated signalling
FLT1|participates_in|VEGF binds to VEGFR leading to receptor dimerization
FLT4|participates_in|VEGF binds to VEGFR leading to receptor dimerization
NGFR|participates_in|Signal Transduction
FLT1|causes or contributes to condition|sarcomatoid renal cell carcinoma
MET|causes or contributes to condition|sarcomatoid renal cell carcinoma
PDGFRA|participates_in|Signaling by VEGF
PDGFRB|participates_in|Signaling by VEGF
FLT1|causes or contributes to condition|Clear cell renal cell carcinoma
TEK|causes or contributes to condition|Clear cell renal cell carcinoma
FLT3|subClassOf|protein_coding_gene
NTRK1|participates_in|Signal Transduction
FLT4|participates_in|Signal Transduction
MET|participates_in|Signaling by VEGF
FLT4|causes or contributes to condition|Clear cell renal cell carcinoma
MET|participates_in|Signaling by NTRKs
PDGFRA|participates_in|Signaling by NTRKs
PDGFRB|participates_in|Signaling by NTRKs
TEK|participates_in|Signaling by NTRKs
NTRK1|participates_in|Signaling by NTRKs
NTRK2|participates_in|Signaling by NTRKs
MET|participates_in|SOS-mediated signalling
MET|participates_in|Signaling by Interleukins
MET|causes or contributes to condition|Neuroblastoma
NTRK1|causes or contributes to condition|Neuroblastoma
NTRK2|causes or contributes to condition|gemistocytic astrocytoma
PDGFRA|participates_in|SOS-mediated signalling
PDGFRA|causes or contributes to condition|Burkitt lymphoma
FLT3|causes or contributes to condition|Burkitt lymphoma
PDGFRA|participates_in|Signaling by NTRK1 (TRKA)
PDGFRB|participates_in|IRS-related events triggered by IGF1R
PDGFRB|participates_in|SOS-mediated signalling
PDGFRB|participates_in|Signaling by NTRK1 (TRKA)
TEK|participates_in|IGF1R signaling cascade
TEK|participates_in|Signalling to p38 via RIT and RIN
NTRK1|participates_in|Signalling to p38 via RIT and RIN
TEK|participates_in|Signaling by NTRK1 (TRKA)
NTRK1|participates_in|NGF-independant TRKA activation
NTRK2|participates_in|NGF-independant TRKA activation
GNAI2|causes or contributes to condition|Carcinoma
CDC42|causes or contributes to condition|Carcinoma
RHOA|causes or contributes to condition|Carcinoma
GNAI2|participates_in|Platelet activation, signaling and aggregation
RAC1|participates_in|Platelet activation, signaling and aggregation
GNAI2|participates_in|Adenylate cyclase inhibitory pathway
GNAI3|participates_in|Adenylate cyclase inhibitory pathway
aflatoxin B1|interacts with|CDC42
aflatoxin B1|molecularly interacts with|macromolecular complex
F-actin|subClassOf|macromolecular complex
CDC42|participates_in|RHO GTPases activate KTN1
RHOA|participates_in|RHO GTPases activate KTN1
CDC42|participates_in|Inactivation of CDC42 and RAC1
RAC1|participates_in|Inactivation of CDC42 and RAC1
valproic acid|interacts with|RHOA
valproic acid|molecularly interacts with|macromolecular complex
RHOA|participates_in|Sema4D mediated inhibition of cell attachment and migration
RAC1|participates_in|Sema4D mediated inhibition of cell attachment and migration
RAC1|causes or contributes to condition|dilated cardiomyopathy 1A
hydralazine|is substance that treats|dilated cardiomyopathy 1A
hydralazine|molecularly interacts with|macromolecular complex
RAC1|participates_in|RHO GTPases activate KTN1
GNAI3|participates_in|Platelet activation, signaling and aggregation
CDC42|participates_in|Platelet activation, signaling and aggregation
RHOA|participates_in|Platelet activation, signaling and aggregation
PRKACA|causes or contributes to condition|Neoplasm of the adrenal gland
CDC42|causes or contributes to condition|Neoplasm of the adrenal gland
PRKACA|participates_in|VEGFA-VEGFR2 Pathway
RHOA|participates_in|VEGFA-VEGFR2 Pathway
PRKACA|participates_in|MAPK6/MAPK4 signaling
RAC1|participates_in|MAPK6/MAPK4 signaling
PRKACA|participates_in|PKA-mediated phosphorylation of key metabolic factors
PRKACB|participates_in|PKA-mediated phosphorylation of key metabolic factors
PRKACG|participates_in|PKA-mediated phosphorylation of key metabolic factors
PRKACA|participates_in|PKA activation
PRKAR1A|participates_in|PKA activation
PRKAR1B|participates_in|PKA activation
PRKAR2A|participates_in|PKA activation
PRKAR2B|participates_in|PKA activation
PRKACB|participates_in|MAPK6/MAPK4 signaling
CDC42|participates_in|MAPK6/MAPK4 signaling
PRKACB|participates_in|VEGFA-VEGFR2 Pathway
PRKACB|participates_in|PKA activation in glucagon signalling
PRKAR1A|participates_in|PKA activation in glucagon signalling
PRKAR1B|participates_in|PKA activation in glucagon signalling
PRKAR2A|participates_in|PKA activation in glucagon signalling
PRKACB|participates_in|PKA activation
PRKACG|participates_in|MAPK6/MAPK4 signaling
PRKACG|participates_in|VEGFA-VEGFR2 Pathway
PRKACG|participates_in|PKA activation in glucagon signalling
PRKAR2B|participates_in|PKA activation in glucagon signalling
PRKAR1A|participates_in|Factors involved in megakaryocyte development and platelet production
CDC42|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR1A|causes or contributes to condition|Frontal balding
RHOA|causes or contributes to condition|Frontal balding
RAC1|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR1B|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR1B|participates_in|Signaling by NTRK1 (TRKA)
RHOA|participates_in|Signaling by NTRK1 (TRKA)
PRKACA|participates_in|PKA activation in glucagon signalling
PRKACG|participates_in|PKA activation
PRKAR2A|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR2A|participates_in|Signaling by NTRK1 (TRKA)
PRKAR2B|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR2B|participates_in|Signaling by NTRK1 (TRKA)
CDH1|causes or contributes to condition|mesothelioma
NF2|causes or contributes to condition|mesothelioma
CDH1|participates_in|Adherens junctions interactions
CDH10|participates_in|Adherens junctions interactions
CDH11|participates_in|Adherens junctions interactions
CDH12|participates_in|Adherens junctions interactions
CDH13|participates_in|Adherens junctions interactions
CDH15|participates_in|Adherens junctions interactions
CDH1|subClassOf|protein_coding_gene
CDH16|subClassOf|protein_coding_gene
CDH17|participates_in|Adherens junctions interactions
CDH18|participates_in|Adherens junctions interactions
CDH19|subClassOf|protein_coding_gene
CDH2|participates_in|Adherens junctions interactions
CDH20|subClassOf|protein_coding_gene
CDH22|subClassOf|protein_coding_gene
CDH24|participates_in|Adherens junctions interactions
CDH3|participates_in|Adherens junctions interactions
CDH4|participates_in|Adherens junctions interactions
CDH5|participates_in|Adherens junctions interactions
CDH6|participates_in|Adherens junctions interactions
CDH7|participates_in|Adherens junctions interactions
CDH8|participates_in|Adherens junctions interactions
CDH9|participates_in|Adherens junctions interactions
MTOR|causes or contributes to condition|mesothelioma
NF2|participates_in|Signal Transduction
STK3|participates_in|Signal Transduction
STK4|participates_in|Signal Transduction
CDH10|subClassOf|protein_coding_gene
NF2|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH10
aflatoxin B1|interacts with|CDH19
aflatoxin B1|interacts with|CDH20
aflatoxin B1|interacts with|CDH22
CDH11|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH11
CDH12|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH12
CDH13|subClassOf|protein_coding_gene
CDH15|subClassOf|gene
NF2|subClassOf|gene
CDH15|subClassOf|protein_coding_gene
valproic acid|interacts with|CDH15
valproic acid|interacts with|CDH19
CDH15|participates_in|Myogenesis
CDH2|participates_in|Myogenesis
CDH4|participates_in|Myogenesis
CDH17|subClassOf|protein_coding_gene
CDH18|subClassOf|protein_coding_gene
CDH2|subClassOf|protein_coding_gene
CDH24|subClassOf|protein_coding_gene
CDH3|subClassOf|protein_coding_gene
CDH4|subClassOf|protein_coding_gene
CDH5|subClassOf|protein_coding_gene
CDH6|subClassOf|protein_coding_gene
CDH7|subClassOf|protein_coding_gene
CDH8|subClassOf|protein_coding_gene
CDH9|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH18
valproic acid|interacts with|CDH2
valproic acid|interacts with|CDH4
aflatoxin B1|interacts with|CDH5
aflatoxin B1|interacts with|CDH6
aflatoxin B1|interacts with|CDH7
aflatoxin B1|interacts with|CDH8
valproic acid|interacts with|CDH9
CDH2|subClassOf|gene
CDH22|causes or contributes to condition|Neoplasm of the large intestine
CDH5|causes or contributes to condition|Neoplasm of the large intestine
CDH7|causes or contributes to condition|Neoplasm of the large intestine
CDH3|subClassOf|gene
CDH5|participates_in|Signal Transduction
temozolomide|molecularly interacts with|macromolecular complex
temozolomide|is substance that treats|gemistocytic astrocytoma
LATS2|causes or contributes to condition|gemistocytic astrocytoma
diethylstilbestrol|molecularly interacts with|macromolecular complex
diethylstilbestrol|is substance that treats|Epithelial neoplasm
LATS1|causes or contributes to condition|Epithelial neoplasm
GNA11|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
PLCB1|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
PLCB2|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
PLCB3|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
GNA11|causes or contributes to condition|Cutaneous melanoma
PLCB4|causes or contributes to condition|Cutaneous melanoma
GNA11|causes or contributes to condition|Iris melanoma
GNAQ|causes or contributes to condition|Iris melanoma
PLCB1|participates_in|Acetylcholine regulates insulin secretion
PRKCA|participates_in|Acetylcholine regulates insulin secretion
PLCB1|participates_in|Beta-catenin independent WNT signaling
PRKCB|participates_in|Beta-catenin independent WNT signaling
PLCB1|participates_in|PLC beta mediated events
PRKCD|participates_in|PLC beta mediated events
PLCB1|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCE|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCG|participates_in|PLC beta mediated events
PRKCH|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PLCB1|causes or contributes to condition|Bipolar affective disorder
PRKCI|causes or contributes to condition|Bipolar affective disorder
PRKCQ|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCZ|causes or contributes to condition|Bipolar affective disorder
PLCB1|participates_in|Metabolism
PRKD3|participates_in|Metabolism
PLCB1|participates_in|Synthesis of IP3 and IP4 in the cytosol
PLCB4|participates_in|Synthesis of IP3 and IP4 in the cytosol
PLCB2|participates_in|Acetylcholine regulates insulin secretion
PLCB2|participates_in|Beta-catenin independent WNT signaling
PLCB2|participates_in|PLC beta mediated events
PLCB2|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PLCB2|participates_in|Signal Transduction
PRKCI|participates_in|Signal Transduction
PRKCZ|participates_in|Signal Transduction
PLCB2|participates_in|Metabolism
PLCB2|participates_in|Synthesis of IP3 and IP4 in the cytosol
PLCB3|participates_in|Acetylcholine regulates insulin secretion
PLCB3|participates_in|Beta-catenin independent WNT signaling
PLCB3|participates_in|PLC beta mediated events
PLCB3|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PLCB3|participates_in|Signal Transduction
PLCB3|participates_in|Metabolism
PLCB3|participates_in|Synthesis of IP3 and IP4 in the cytosol
PLCB4|participates_in|PLC beta mediated events
PRKCA|participates_in|PLC beta mediated events
PLCB4|participates_in|GPCR downstream signalling
PRKCB|participates_in|GPCR downstream signalling
PLCB4|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PLCB4|participates_in|Signal Transduction
PLCB4|participates_in|Metabolism
GNAQ|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
GNAQ|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKAA1|participates_in|Generic Transcription Pathway
WWTR1|participates_in|Generic Transcription Pathway
YAP1|participates_in|Generic Transcription Pathway
PRKAA1|participates_in|PKB-mediated events
PRKAA2|participates_in|PKB-mediated events
PRKAB1|participates_in|PKB-mediated events
PRKAB2|participates_in|PKB-mediated events
PRKAG1|participates_in|PKB-mediated events
PRKAG2|participates_in|PKB-mediated events
PRKAG3|participates_in|PKB-mediated events
WWTR1|causes or contributes to condition|epithelioid hemangioendothelioma
YAP1|causes or contributes to condition|epithelioid hemangioendothelioma
PRKAA2|participates_in|Generic Transcription Pathway
PRKAA2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAB1|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAA2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAB2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAG1|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAG2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAG3|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAB1|participates_in|Generic Transcription Pathway
PRKAB2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAG2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAB2|participates_in|Generic Transcription Pathway
PRKAG1|participates_in|Generic Transcription Pathway
PRKAG2|participates_in|Generic Transcription Pathway
PRKAG3|participates_in|Generic Transcription Pathway
LEF1|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
TCF7L1|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
TCF7L2|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
TCF7|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
CTNNB1|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
SMAD3|participates_in|SMAD4 MH2 Domain Mutants in Cancer
SMAD2|participates_in|SMAD4 MH2 Domain Mutants in Cancer
PRKCA|participates_in|Signaling by EGFR
CDC42|participates_in|Signaling by EGFR
PRKCA|participates_in|Signaling by ERBB2
RHOA|participates_in|Signaling by ERBB2
PRKCA|participates_in|PCP/CE pathway
RAC1|participates_in|PCP/CE pathway
PRKCA|participates_in|Disinhibition of SNARE formation
PRKCB|participates_in|Disinhibition of SNARE formation
PRKCA|participates_in|HuR (ELAVL1) binds and stabilizes mRNA
PRKCD|participates_in|HuR (ELAVL1) binds and stabilizes mRNA
PRKCA|participates_in|PLC-gamma1 signalling
PRKCE|participates_in|PLC-gamma1 signalling
PRKCG|participates_in|Disinhibition of SNARE formation
PRKCA|participates_in|G alpha (z) signalling events
PRKCH|participates_in|G alpha (z) signalling events
PRKCA|participates_in|Signaling by NTRKs
PRKCI|participates_in|Signaling by NTRKs
PRKCA|participates_in|Inactivation, recovery and regulation of the phototransduction cascade
PRKCQ|participates_in|Inactivation, recovery and regulation of the phototransduction cascade
PRKCA|participates_in|VEGFR2 mediated cell proliferation
PRKCZ|participates_in|VEGFR2 mediated cell proliferation
PRKCA|participates_in|Metabolism
PRKCB|participates_in|VEGFA-VEGFR2 Pathway
CDC42|participates_in|VEGFA-VEGFR2 Pathway
PRKCB|participates_in|PCP/CE pathway
RHOA|participates_in|PCP/CE pathway
PRKCB|participates_in|G alpha (z) signalling events
PRKCD|participates_in|G alpha (z) signalling events
PRKCE|participates_in|G alpha (z) signalling events
PRKCB|participates_in|Signal Transduction
PRKCQ|participates_in|G alpha (z) signalling events
PRKCB|participates_in|VEGFR2 mediated cell proliferation
PRKCB|subClassOf|protein_coding_gene
PRKD3|subClassOf|protein_coding_gene
PRKCD|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
CDC42|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
PRKCD|participates_in|Signaling by ERBB2
RAC1|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
PRKCD|participates_in|PLC-gamma1 signalling
PRKCG|participates_in|PLC-gamma1 signalling
PRKCD|participates_in|Effects of PIP2 hydrolysis
PRKCH|participates_in|Effects of PIP2 hydrolysis
PRKCD|participates_in|Signaling by NTRKs
PRKCQ|participates_in|Effects of PIP2 hydrolysis
PRKCD|participates_in|VEGFR2 mediated cell proliferation
PRKCD|subClassOf|protein_coding_gene
PRKCE|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
PRKCE|participates_in|Signaling by ERBB2
PRKCE|participates_in|Effects of PIP2 hydrolysis
PRKCE|participates_in|Signaling by NTRKs
PRKCE|causes or contributes to condition|Allodynia
PRKCZ|causes or contributes to condition|Allodynia
PRKCE|subClassOf|protein_coding_gene
PRKCG|participates_in|Signaling by EGFR
PRKCG|participates_in|PCP/CE pathway
PRKCG|participates_in|G alpha (z) signalling events
PRKCG|participates_in|Signaling by NTRKs
PRKCG|causes or contributes to condition|Allodynia
valproic acid|interacts with|PRKCG
valproic acid|interacts with|PRKD3
PRKCH|participates_in|Platelet activation, signaling and aggregation
PRKCH|participates_in|Signal Transduction
PRKCZ|participates_in|Platelet activation, signaling and aggregation
PRKCH|subClassOf|protein_coding_gene
CDC42|participates_in|Signal Transduction
PRKCI|participates_in|p75 NTR receptor-mediated signalling
RHOA|participates_in|p75 NTR receptor-mediated signalling
RAC1|participates_in|p75 NTR receptor-mediated signalling
PRKCQ|participates_in|Signal Transduction
PRKCI|subClassOf|protein_coding_gene
PRKCQ|participates_in|Netrin-1 signaling
CDC42|participates_in|Netrin-1 signaling
PRKCQ|causes or contributes to condition|Cutaneous T-cell lymphoma
RHOA|causes or contributes to condition|Cutaneous T-cell lymphoma
RAC1|participates_in|Netrin-1 signaling
PRKCQ|participates_in|Platelet activation, signaling and aggregation
PRKCQ|subClassOf|protein_coding_gene
PRKCZ|participates_in|GPVI-mediated activation cascade
CDC42|participates_in|GPVI-mediated activation cascade
PRKCZ|participates_in|TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
RHOA|participates_in|TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
RAC1|participates_in|GPVI-mediated activation cascade
valproic acid|interacts with|PRKCZ
CDC42|subClassOf|protein_coding_gene
RAC1|subClassOf|protein_coding_gene
LATS2|participates_in|Signaling by Hippo
WWTR1|participates_in|Signaling by Hippo
YAP1|participates_in|Signaling by Hippo
LATS1|causes or contributes to condition|gemistocytic astrocytoma
LATS1|participates_in|Signaling by Hippo
GNAL|participates_in|G-protein mediated events
PRKACA|participates_in|G-protein mediated events
PRKACB|participates_in|G-protein mediated events
PRKACG|participates_in|G-protein mediated events
PRKAR1A|participates_in|G-protein mediated events
PRKAR1B|participates_in|G-protein mediated events
PRKAR2A|participates_in|G-protein mediated events
PRKAR2B|participates_in|G-protein mediated events
GNAL|causes or contributes to condition|Schizophrenia
GNAS|causes or contributes to condition|Schizophrenia
GNAS|causes or contributes to condition|Neoplasm of the adrenal gland
GNAS|participates_in|PKA activation in glucagon signalling
STK3|participates_in|Signaling by Hippo
LATS2|participates_in|Signal Transduction
LATS1|participates_in|Signal Transduction
TEAD1|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD2|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD3|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD4|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
